Still, provided that 23andMe ensures that all patients are given adequate informed consent and the resulting data is considered valid by the scientific community, this could prove to be an efficient new way to conduct scientific research.
Each day of accelerometer data was considered valid if data were obtained for at least 500 minutes.
Data were considered valid only if each bin contained on average one or more events (i.e., total >160 events).
The data were considered "valid" only if results were obtained for three of the four slides tested.
The accelerometer data was considered valid only when 10 or more hours of data per day were collected for five days.
Accelerometry data were considered valid if counts were present for at least three days with at least 8 hours of recording per day.
Data were considered valid if the relative amount of the reference gene for a sample was constant (i.e. was similar in both duplicates) and the average amount was used as a normalization factor in the ΔΔ CT method.
Array data were considered valid if the fold change of each gene tested by RT-qPCR was log2 x) > 0.66 or log2(1/x) < −0.66 (representing a plain fold-change > 1.5) and consistent with microarray analysis.
Each patient's ActiGraph data was considered valid if there were ≥10 hours of wear-time per day for ≥5 days, to include a Saturday or Sunday [ 23, 24].
Accelerometer data were considered valid if over 600 minutes (10 hours) of monitoring per day (excluding strings of zeros for 20 minutes or longer) was recorded over the entire monitoring period [ 33].
